NinePointTwo Capital’s CareDx CDNA Stock Holding History

NinePointTwo Capital’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-14,302	Closed	-$529K	–	208
2022 Q1	$529K	Buy	+14,302	New	+$557K	0.14%	38

Other funds holding CDNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

NinePointTwo Capital's CDNA Position: Q2 2022 in Review

NinePointTwo Capital sold out of CareDx (CDNA) in Q2 2022, closing a stake of 14,302 shares — an estimated $529K sold.

NinePointTwo Capital first reported a position in CDNA in Q1 2022 and held it in 1 quarter. The position peaked at $529K in Q1 2022. 184 funds tracked by Wall St. Rank hold CDNA as of Q2 2022.

NinePointTwo Capital reported no remaining CareDx position as of Q2 2022 after selling out during the quarter.
NinePointTwo Capital sold 14,302 CareDx shares in Q2 2022, an estimated $529K.
NinePointTwo Capital first reported a position in CareDx in Q1 2022 and held it in 1 quarter.
NinePointTwo Capital's CareDx position peaked at $529K in Q1 2022.
184 funds tracked by Wall St. Rank held CareDx as of Q2 2022.

Based on NinePointTwo Capital's 13F filing for Q2 2022, filed 15 Aug 2022.